TEVA - Teva Pharmaceutical Industries Limited

NYSE - NYSE Delayed Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/12/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
12.51B10.00B10.79B7.50B10.08B
Enterprise Value 3
37.22B35.36B36.89B34.49B37.15B
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
4.683.673.872.723.91
PEG Ratio (5 yr expected) 1
6.830.731.140.741.06
Price/Sales (ttm)
0.740.580.600.410.53
Price/Book (mrq)
0.940.700.780.530.68
Enterprise Value/Revenue 3
2.188.129.248.098.57
Enterprise Value/EBITDA 6
27.5559.9459.21103.87-191.51

Trading Information

Stock Price History

Beta (5Y Monthly) 1.66
52-Week Change 343.41%
S&P500 52-Week Change 36.03%
52 Week High 313.76
52 Week Low 36.07
50-Day Moving Average 312.25
200-Day Moving Average 310.80

Share Statistics

Avg Vol (3 month) 310.88M
Avg Vol (10 day) 36.34M
Shares Outstanding 51.1B
Float 1.09B
% Held by Insiders 10.60%
% Held by Institutions 154.67%
Shares Short (Jun 29, 2020) 421.87M
Short Ratio (Jun 29, 2020) 42.4
Short % of Float (Jun 29, 2020) 4N/A
Short % of Shares Outstanding (Jun 29, 2020) 42.00%
Shares Short (prior month May 28, 2020) 417.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 11, 2017
Ex-Dividend Date 4Nov 26, 2017
Last Split Factor 22:1
Last Split Date 3Jun 30, 2004

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin -4.83%
Operating Margin (ttm)17.61%

Management Effectiveness

Return on Assets (ttm)3.27%
Return on Equity (ttm)-5.78%

Income Statement

Revenue (ttm)17.1B
Revenue Per Share (ttm)15.66
Quarterly Revenue Growth (yoy)5.00%
Gross Profit (ttm)7.54B
EBITDA 4.69B
Net Income Avi to Common (ttm)-825M
Diluted EPS (ttm)-0.76
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.8B
Total Cash Per Share (mrq)1.65
Total Debt (mrq)26.51B
Total Debt/Equity (mrq)181.75
Current Ratio (mrq)1.05
Book Value Per Share (mrq)12.35

Cash Flow Statement

Operating Cash Flow (ttm)941M
Levered Free Cash Flow (ttm)2.54B